Search

Your search keyword '"Generic drugs -- Product introduction"' showing total 414 results
Start Over Descriptor "Generic drugs -- Product introduction"
414 results on '"Generic drugs -- Product introduction"'

1. Generic Version of Victoza, a GLP-1 Receptor Agonist, Now Available

Author

Park, Brian

Subjects
Diabetes therapy -- Product introduction, Generic drugs -- Product introduction, Liraglutide, Type 2 diabetes -- Drug therapy, Health, Victoza (Medication) -- Product introduction
Abstract

Teva has launched an authorized generic version of https://www.empr.com/drug/victoza/ (liraglutide injection). Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated: as an adjunct to diet and exercise to improve glycemic [...]

Published
2024

2. Endo Launches Tiopronin Delayed-Release Tablets, Generic Version of THIOLA EC

Subjects
Generic drugs -- Product introduction, Health care industry -- Product introduction, Tiopronin -- Product introduction, Health care industry, Business, News, opinion and commentary, Thiola (Medication) -- Product introduction
Abstract

MALVERN, Pa., July 15, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today the launch of tiopronin delayed-release tablets, a generic version of Travere Therapeutics' THIOLA EC. 'We're proud to [...]

Published
2024

3. Meitheal Pharmaceuticals Announces Expansion of Portfolio of Generic Injectable Products

Subjects
United States. Food and Drug Administration, Generic drugs -- Product introduction, Business, Business, international
Abstract

* Asset purchase agreement by parent company Hong Kong King-Friend adds 18 new products to Meitheal's robust generics portfolio CHICAGO -- Meitheal Pharmaceuticals, Inc. ('Meitheal'), a fully integrated generic injectables [...]

Published
2023

4. Endo Launches Dexlansoprazole Capsules, Generic Version of Dexilant

Subjects
Par Pharmaceutical Inc. -- Product introduction, Generic drugs -- Product introduction, Rilpivirine -- Product introduction, Pharmaceutical industry -- Product introduction, Business, News, opinion and commentary
Abstract

DUBLIN, June 15, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., has begun shipping dexlansoprazole 30 mg capsules, a [...]

Published
2023

5. Generic Version of Cystadane Now Available

Author

Park, Brian

Subjects
Generic drugs -- Product introduction, Drug approval, Health, Cystadane (Medication) -- Product introduction
Abstract

The first generic version of Cystadane[sup.®] (betaine anhydrous for oral solution) Powder has been made available by Oakrum Pharma, LLC, in collaboration with ANI Pharmaceuticals. Betaine Anhydrous Powder is a [...]

Published
2022

6. Generic Version of Cuvposa Now Available

Author

Park, Brian

Subjects
Generic drugs -- Product introduction, Oral medication -- Product introduction, Health, Cuvposa (Medication) -- Product introduction
Abstract

The first generic version of Cuvposa[sup.®] (glycopyrrolate) Oral Solution has been made available by Endo International. Glycopyrrolate Oral Solution is an anticholinergic indicated to reduce chronic severe drooling in patients [...]

Published
2022

7. Teva Launches New 'Pivot to Growth' Strategy

Subjects
Teva Pharmaceutical Industries Ltd. -- Product introduction -- Growth, Investment analysis -- Product introduction, Generic drugs -- Product introduction, Pharmaceutical industry -- Product introduction -- Growth, Company growth, Business, Business, international, Austedo (Medication) -- Product introduction
Abstract

* Return to growth by accelerating a strong innovative medicines portfolio * Expand innovative pipeline and focus on core therapeutic areas with first-in-class and best-in-class opportunities * Sustain generics powerhouse [...]

Published
2023

8. Sandoz to exclusively commercialize six products in the US, reinforcing global leadership position in off-patent medicines

Subjects
Sandoz Inc. -- Intellectual property -- Product introduction, Novartis AG -- Intellectual property -- Product introduction, Generic drugs -- Product introduction, Pharmaceutical industry -- Product introduction -- Intellectual property, Business, international
Abstract

(GLOBE NEWSWIRE via COMTEX) -- - Agreement offers exclusive rights to commercialize six products in key areas of anti-infectives and oncology. - Products from Adalvo slated for near- to mid-term [...]

Published
2023

9. Endo Launches First Generic Version of Pylera (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) Capsules

Subjects
Par Pharmaceutical Inc. -- Product introduction, Tetracycline -- Product introduction, Nonprescription drugs -- Product introduction, Generic drugs -- Product introduction, Metronidazole -- Product introduction, Drug approval, Tetracyclines -- Product introduction, Pharmaceutical industry -- Product introduction, Business, News, opinion and commentary
Abstract

DUBLIN, March 10, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., has begun shipping the first generic version of [...]

Published
2023

10. West Pharma expands its NovaGuard SA Pro Safety System offerings in India with launch of 0.5ml syringe device

Subjects
West Pharmaceutical Services Inc. -- Product introduction, Generic drugs -- Product introduction, Packaging industry -- Product introduction, Pharmaceuticals and cosmetics industries
Abstract

Byline: Our Bureau West Pharmaceutical Services, Inc. (West), a global leader in innovative solutions for injectable drug and healthcare products, has introduced NovaGuard SA Pro Safety System, a single-use accessory [...]

Published
2021

11. UPSHER-SMITH EXPANDS FLUOXETINE PRODUCT LINE TO INCLUDE AN ORAL SOLUTION

Subjects
Generic drugs -- Product introduction, Fluoxetine -- Product introduction, Oral medication -- Product introduction, General interest, News, opinion and commentary
Abstract

MAPLE GROVE: Upsher-Smith Laboratories, LLC has issued the following news release: Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has expanded its fluoxetine product family with the launch of Fluoxetine [...]

Published
2023

12. FDA RELEASES NEW DRAFT GUIDANCES ON TOPICAL GENERIC DRUGS

Subjects
United States. Food and Drug Administration, Generic drugs -- Product introduction, News, opinion and commentary
Abstract

ROCKVILLE, MD -- The following information was released by the Regulatory Affairs Professionals Society: By Jeff Craven The US Food and Drug Administration (FDA) recently released several new draft guidances [...]

Published
2022

13. Methylphenidate long-acting (modified-release) preparations: caution if switching between products due to differences in formulations

Subjects
Methylphenidate -- Product introduction, Generic drugs -- Product introduction, Methylphenidate hydrochloride -- Product introduction, Medical personnel, Business, international
Abstract

London: UK Government has issued the following news release: Prescribers and dispensers should use caution if switching patients between different long-acting formulations of methylphenidate (Concerta XL, Medikinet XL, Equasym XL, [...]

Published
2022

14. West Pharma launches AccelTRA RTS/RTU product line for generic injectable drug sector

Subjects
West Pharmaceutical Services Inc. -- Product introduction, Drug delivery systems -- Product introduction, Generic drugs -- Product introduction, Packaging industry -- Product introduction, Pharmaceutical industry -- Product introduction, Pharmaceuticals and cosmetics industries
Abstract

Byline: Our Bureau West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, has introduced the AccelTRA ready to sterilize (RTS) and ready to use (RTU) [...]

Published
2020

15. Sandoz Canada expands its generics portfolio with three new products

Subjects
Sandoz Canada Inc. -- Product introduction, Generic drugs -- Product introduction, Multiple sclerosis -- Care and treatment, Pharmaceutical industry -- Product introduction, Business, international
Abstract

(GlobeNewswire) - Sandoz Canada Inc. is proud to announce a series of product launches this spring that are expanding the companys portfolio of high-quality generic medicines. During the spring, Sandoz [...]

Published
2022

16. Sandoz Canada expands its generics portfolio with three new products

Subjects
Generic drugs -- Product introduction, Multiple sclerosis -- Care and treatment, Banking, finance and accounting industries, Business
Abstract

BOUCHERVILLE, Quebec, Jul 05, 2022 (GLOBE NEWSWIRE via COMTEX) -- EQNX::TICKER_START EQNX::TICKER_END Sandoz Canada Inc. is proud to announce a series of product launches this spring that are expanding the [...]

Published
2022

18. Sandoz launches generic brimonidine tartrate/timolol maleate eyedrop in US for patients with ocular hypertension, expanding leading ophthalmic portfolio

Subjects
Sandoz Inc. -- Product introduction, Novartis AG -- Product introduction, Brimonidine -- Product introduction, Generic drugs -- Product introduction, Pharmaceutical industry -- Product introduction, Hypertension -- Care and treatment, Business, international
Abstract

(GLOBE NEWSWIRE via COMTEX) -- - Brimonidine tartrate/timolol maleate combination eyedrop is used to treat elevated eye pressure in patients with ocular hypertension1 - Ocular hypertension affects over 5% of [...]

Published
2022

19. New Pharmaceuticals Study Findings Have Been Reported by Investigators at Food and Drug Administration (Dosage Unit Uniformity and Dissolution Testing of Extended-release Pharmaceutical Products Marketed In the Us)

Subjects
United States. Food and Drug Administration -- Reports, Generic drugs -- Product introduction, Business, Health, Health care industry
Abstract

2022 NOV 6 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- A new study on Pharmaceuticals is now available. According to [...]

Published
2022

20. Amneal Expands Injectables Portfolio with 4 New Products

Subjects
United States. Food and Drug Administration, Generic drugs -- Product introduction, Central nervous system depressants -- Product introduction, Dexamethasone -- Product introduction, Tromethamine -- Product introduction, Drug approval, Carboprost -- Product introduction, Business, Business, international
Abstract

- Launching Dexamethasone, Azacitidine, Carboprost, and Atropine for the Institutional Market BRIDGEWATER, N.J. -- Amneal Pharmaceuticals, Inc. (NYSE: AMRX) ('Amneal' or the 'Company') today announced the approval of four generic [...]

Published
2022

21. Eagle Pharmaceuticals Announces Commercial Availability of Vasopressin

Subjects
Eagle Pharmaceuticals Inc. -- Product introduction, Vasopressin -- Product introduction, Generic drugs -- Product introduction, Pharmaceutical industry -- Product introduction, Business, Business, international
Abstract

-- Shipment of vasopressin, a generic alternative to Vasostrict([R]),commences today, with 180 days of marketing exclusivity -- -- Product launch expected to drive significant revenue growth in 2022 -- WOODCLIFF [...]

Published
2022

22. HOW MODELING WAS USED TO SUPPORT THE FDA APPROVAL OF A TOPICAL GENERIC DRUG PRODUCT

Subjects
United States. Food and Drug Administration, Diclofenac -- Product introduction, Generic drugs -- Product introduction, Drug approval, News, opinion and commentary
Abstract

SILVER SPRING, MD -- The following information was released by the U.S. Food and Drug Administration (FDA): CDER Researchers have been investigating how pharmacokinetic (PK) modeling can support a determination [...]

Published
2021

23. BWX Technologies: Indium In-111 Oxyquinoline Solution now available in U.S

Subjects
BWX Technologies Inc. -- Product introduction, Nuclear industry -- Product introduction, Generic drugs -- Product introduction, Indium -- Product introduction, Technology, Backup software, Business, News, opinion and commentary
Abstract

BWX Technologies announced that subsidiary BWXT ITG Canada, having received approval from the U.S. FDA on its abbreviated new drug application for its generic version of Indium In-111 Oxyquinoline Solution, [...]

Published
2019

24. ANI Pharmaceuticals Announces Two Generic Product Launches

Subjects
ANI Pharmaceuticals Inc. -- Product introduction, Generic drugs -- Product introduction, Pharmaceutical industry -- Product introduction, Obesity, Erythromycin, Attention deficit hyperactivity disorder, Physical fitness, Hyperactivity, Antibacterial agents, Methylphenidate, Infection, Oral drugs, Editors, Health
Abstract

2019 APR 13 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- ANI Pharmaceuticals, Inc. ('ANI' or the 'Company') (Nasdaq: ANIP) announced the launch [...]

Published
2019

26. Sandoz introduces generic, applies for biosimilar

Subjects
Sandoz AG -- Product development -- Product introduction, Drugs -- Overdose, Generic drugs -- Product introduction, Naloxone -- Product introduction, Pharmaceutical industry -- Product development -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Retail industry
Abstract

PRINCETON, N.J. -- Sandoz has launched an authorized generic of Narcan (naloxone hydrochloride) nasal spray 4 mg, which is used to reverse opioid overdose. It is immediately available to people [...]

Published
2022

27. Generic Injectables Market to Exceed US$ 307 Bn Value by 2031; Players Focus on Increasing Patient Compliance and New Product Launches, States TMR Report

Subjects
United States. Food and Drug Administration -- Reports, Patient compliance -- Forecasts and trends -- Reports, Generic drugs -- Product introduction, Drug approval -- Forecasts and trends -- Reports, Market trend/market analysis, Business, News, opinion and commentary
Abstract

- Major players in the generic injectables market are increasing R&D activities, which focus on development of products intended for the treatment of cardiology and oncology health issues - Focus [...]

Published
2021

28. Endo Launches First and Only Generic Version of Chantix (varenicline) Tablets in the United States

Subjects
Par Pharmaceutical Inc. -- Product introduction, Generic drugs -- Product introduction, Financial statements, Drug approval, Pharmaceutical industry -- Product introduction, Business, News, opinion and commentary, Chantix (Medication) -- Product introduction
Abstract

DUBLIN, Sept. 22, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), has begun shipping the generic version of [...]

Published
2021

29. Teva Announces Its Launch of the First Generic PERFOROMIST[R], Formoterol Fumarate Inhalation Solution, 20 mcg/2 ML, Used to Treat Chronic Obstructive Pulmonary Disease (COPD), in the United States

Subjects
Teva Pharmaceutical Industries Ltd. -- Product introduction, Bronchitis -- Care and treatment, Generic drugs -- Product introduction, Formoterol -- Product introduction, Pharmaceutical industry -- Product introduction, Business, Business, international
Abstract

TEL AVIV, Israel & PARSIPPANY, N.J. -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced its U.S. launch of the first generic [...]

Published
2021

30. 'Branded generics' as a strategy to limit cannibalization of pharmaceutical markets

Author

Reiffen, David and Ward, Michael R.

Subjects
Generic drugs -- Market share, Generic drugs -- Product introduction, Generic drugs -- Prices and rates, Brand name products -- Market share, Pharmaceutical industry -- Industry sales and revenue, Company market share, Company pricing policy, Banking, finance and accounting industries, Business, Business, general, Economics
Abstract

Pharmaceutical companies introduce generic versions of their patented drugs to manipulate the balance in market share between generics and brand drugs. The strategy is to sell the generics at a high price, influencing consumers to buy the branded ones instead, which in turn, increases revenue for the company in the branded segment. The implications of branded generic technique are evaluated.

Published
2007

31. Teva Canada announces launch of generic version of Abilify

Subjects
Teva Pharmaceutical Industries Ltd. -- Product introduction, Antipsychotic agents, Generic drugs -- Product introduction, Pharmaceutical industry -- Product introduction, Prescriptions (Drugs) -- Product introduction, Business, News, opinion and commentary, Abilify (Medication) -- Product introduction
Abstract

Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries, announces that the complete line of Teva-Aripiprazole, a Health Canada approved, bioequivalent generic version of Abilify is now available in Canada. [...]

Published
2018

33. Dr. Reddy's, Camber, Aurobindo roll out generics

Subjects
Aurobindo Pharma Ltd. -- Product introduction, Dr. Reddy's Laboratories Ltd. -- Product introduction, Generic drugs -- Product introduction, Pharmaceutical industry -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Retail industry
Abstract

NEW YORK -- Dr. Reddy's Laboratories Ltd., Camber Pharmaceuticals and Aurobindo Pharma Ltd. launched generic drugs this spring. Dr. Reddy's in May introduced ertapenem for injection, 1 g/ vial, a [...]

Published
2021

34. Sanofi proves its pluck

Author

Arnold, Matthew

Subjects
Pfizer Inc. -- Product introduction -- Company sales and earnings, Sanofi S.A. -- Product introduction -- Company sales and earnings, Generic drugs -- Product introduction, Pharmaceutical industry -- Product introduction -- Company sales and earnings, Company earnings/profit, Business, Health care industry, Eloxatin (Medication) -- Product introduction, Avapro (Medication) -- Product introduction, Plavix (Medication) -- Product introduction
Abstract

Sanofi came into 2012 staring down at the steepest patent cliff in the industry. Plavix, for which Sanofi's share of 2011 global sales was $2.6 billion, lost US exclusivity in [...]

Published
2013

35. Pharmascience Inc. launches pms-FLUTICASONE PROPIONATE|SALMETEROL DPI for the maintenance treatment of asthma and COPD

Subjects
Generic drugs -- Product introduction, Fluticasone -- Product introduction, Asthma -- Care and treatment, Chronic obstructive lung disease, Respiratory system agents, Nonprescription drugs, Backup software, Franchises, General interest, News, opinion and commentary, Advair Diskus (Medication) -- Product introduction
Abstract

MONTREAL: Pharmascience Inc. has issued the following press release: Pharmascience Inc. is proud to bring to market a new product for the maintenance treatment of asthma and COPD. pms-FLUTICASONE PROPIONATE/SALMETEROL [...]

Published
2020

36. Upsher-Smith Kicks Off 2020 With Three Generic Product Launches

Subjects
Generic drugs -- Product introduction, Central nervous system depressants -- Product introduction, Fluvoxamine -- Product introduction, Haloperidol -- Product introduction, Business, News, opinion and commentary
Abstract

Company Strengthens its Generic Portfolio with Rapid Product Expansion MAPLE GROVE, Minn., Feb. 19, 2020 /PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has expanded its generic portfolio [...]

Published
2020

37. Armas Pharmaceuticals Adds Four Generic Injectables As First Launches of 2020

Subjects
Sanofi S.A. -- Product introduction, Generic drugs -- Product introduction, Pharmaceutical industry -- Product introduction, Business, News, opinion and commentary
Abstract

MANALAPAN, N.J., Jan. 20, 2020 /PRNewswire/ -- Armas Pharmaceuticals Inc. (Armas), has begun the new year with launches of four generic injectables: Caffeine Citrate, Docetaxel, Gemcitabine and Verapamil HCI. These [...]

Published
2020

38. Novo Nordisk's new insulin affordability offerings now available in the US

Subjects
Novo Nordisk A/S -- Product introduction, Insulin aspart -- Product introduction, Generic drugs -- Product introduction, Insulin -- Product introduction, Pharmaceutical industry -- Product introduction, Business, News, opinion and commentary
Abstract

- My$99Insulin: All patients can purchase up to three vials or two packs of FlexPen/FlexTouch/Penfill pens of any combination of insulins from Novo Nordisk Inc. for $99 - Follow-on brand [...]

Published
2020

39. Teva Announces Its Launch of the First Generic PERFOROMIST®, Formoterol Fumarate Inhalation Solution, 20 mcg/2 ML, Used to Treat Chronic Obstructive Pulmonary Disease COPD, in the United States

Subjects
Teva Pharmaceutical Industries Ltd. -- Product introduction, Bronchitis -- Care and treatment, Generic drugs -- Product introduction, Formoterol -- Product introduction, Pharmaceutical industry -- Product introduction, Health, Health care industry
Abstract

2021 JUL 11 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE [...]

Published
2021

40. Micro Labs, Saptalis Ink Generics Deal, Launch First Product

Subjects
Generic drugs -- Product introduction, Pharmaceutical industry -- Alliances and partnerships -- Product introduction, Dermatologic agents, Oral drugs, Psoriasis, Dermatitis, Business, Pharmaceuticals and cosmetics industries, Retail industry
Abstract

A new generics partnership is bringing oral liquid and topical products to the market. Micro Labs USA and Saptalis Pharmaceuticals have formed a strategic collaboration to launch single-source and multisource [...]

Published
2020

41. Teva Rolls Out Generic Beyaz to the U.S

Subjects
Teva Pharmaceutical Industries Ltd. -- Product introduction, Generic drugs -- Product introduction, Pharmaceutical industry -- Product introduction, Arts and entertainment industries
Abstract

Teva Pharmaceutical Industries reported the launch of Rajanitm (drospirenone, ethinyl estradiol and levomefolate calcium tablets, 3 mg/0.02 mg/0.451 mg and levomefolate calcium tablets, 0.451 mg) in the United States. According [...]

Published
2016

42. Top Portfolio Products: DoubleLine Rolls Out Global Bond Fund

Subjects
Oppenheimer and Company Inc. -- Product introduction, Securities industry -- Product introduction, Bond funds -- Product introduction, Generic drugs -- Product introduction, Bonds (Securities) -- Product introduction, Exchange-traded funds -- Product introduction, Private banking -- Product introduction, Securities industry, Banking, finance and accounting industries
Abstract

Byline: Marlene Y. Satter New products and changes introduced over the last week include a global bond fund from DoubleLine; a generic drug ETF from Van Eck Global; a technology [...]

Published
2016

43. Teva Announces Launch of a Generic Version of Tracleer[R] (bosentan) Tablets in the United States

Subjects
Teva Pharmaceutical Industries Ltd. -- Product introduction, Pulmonary hypertension -- Care and treatment, Birth defects -- Care and treatment, Liver diseases -- Care and treatment, Government investigations, Endothelin, Generic drugs -- Product introduction, Pharmaceutical industry -- Product introduction, Hypertension, Liver, Business, Business, international, Tracleer (Medication) -- Product introduction
Abstract

JERUSALEM -- Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of Tracleer([R]1) (bosentan) tablets, 62.5 mg and 125 mg, in the U.S. [...]

Published
2019

44. Sol-Gel Technologies Announces Seventh Agreement for Generic Product Candidates with Perrigo

Subjects
United States. Food and Drug Administration, Skin diseases -- Care and treatment, Generic drugs -- Product introduction, Antibiotics, Technology, Skin, Production management, Telecommunications industry
Abstract

(GlobeNewswire) - Sol-Gel Technologies, Ltd. (NASDAQ: SLGL) (Sol-Gel or the Company), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment [...]

Published
2019

45. Teva Announces Launch of a Generic Version of Ranexa[R] (ranolazine) Extended-Release Tablets in the United States

Subjects
Teva Pharmaceutical Industries Ltd. -- Product introduction, Ranolazine, Government investigations, Generic drugs -- Product introduction, Pharmaceutical industry -- Product introduction, Drug approval, Angina pectoris, Business, Business, international, Ranexa (Medication) -- Product introduction
Abstract

JERUSALEM -- Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of Ranexa([R]1) (ranolazine) Extended-Release Tablets, 500 mg and 1000 mg, in the [...]

Published
2019

46. Sol-Gel Technologies Announces Seventh Agreement for Generic Product Candidates with Perrigo

Subjects
United States. Food and Drug Administration, Skin diseases -- Care and treatment, Generic drugs -- Product introduction, Antibiotics, Technology, Skin, Production management, Banking, finance and accounting industries, Business
Abstract

NESS ZIONA, Israel, May 28, 2019 (GLOBE NEWSWIRE via COMTEX) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL) ('Sol-Gel' or the 'Company'), a clinical-stage dermatology company focused on identifying, developing and commercializing [...]

Published
2019

47. Teva Announces Launch of a Generic Version of Tarceva(r) (erlotinib) Tablets in the United States

Subjects
Teva Pharmaceutical Industries Ltd. -- Product introduction, Pharmaceutical industry -- Product introduction, Non-small cell lung cancer -- Drug therapy, Generic drugs -- Product introduction, Government investigations, Epidermal growth factors, Erlotinib -- Product introduction, Chemotherapy, Cancer, Tumors, Antineoplastic agents, Cancer metastasis, Small cell lung cancer, Lung cancer, General interest, News, opinion and commentary, Tarceva (Medication) -- Product introduction
Abstract

Petah Tikva: Teva Pharmaceutical Industries Limited has issued the following press release: Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the launch of a generic version of Tarceva(r)1 [...]

Published
2019

48. Teva Announces Launch of a Generic Version of Tarceva[R] (erlotinib) Tablets in the United States

Subjects
Teva Pharmaceutical Industries Ltd. -- Product introduction, Pharmaceutical industry -- Product introduction, Non-small cell lung cancer -- Drug therapy, Generic drugs -- Product introduction, Government investigations, Epidermal growth factors, Erlotinib -- Product introduction, Chemotherapy, Cancer, Tumors, Antineoplastic agents, Cancer metastasis, Small cell lung cancer, Lung cancer, Business, Business, international, Tarceva (Medication) -- Product introduction
Abstract

JERUSALEM -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the launch of a generic version of Tarceva([R]1) (erlotinib) tablets, 100 and 150 mg, in the U.S. Erlotinib [...]

Published
2019

49. Teva Announces Launch of a Generic Version of Letairis[R] (ambrisentan) Tablets in the United States

Subjects
Teva Pharmaceutical Industries Ltd. -- Product introduction, Pharmaceutical industry -- Product introduction, Risk assessment, Government investigations, Endothelin, Ambrisentan, Pulmonary hypertension -- Development and progression -- Care and treatment, Generic drugs -- Product introduction, Tadalafil, Hypertension, Business, Business, international, Letairis (Medication) -- Product introduction
Abstract

JERUSALEM -- Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of Letairis([R]1) (ambrisentan) Tablets, 5 mg and 10 mg, in the U.S. [...]

Published
2019

50. Teva Announces Launch of a Generic Version of VESIcare[R] (solifenacin succinate) Tablets in the United States

Subjects
Teva Pharmaceutical Industries Ltd. -- Product introduction, Pharmaceutical industry -- Product introduction, Government investigations, Solifenacin -- Product introduction, Urinary incontinence -- Care and treatment, Generic drugs -- Product introduction, Incontinence, Business, Business, international
Abstract

JERUSALEM -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the launch of a generic version of VESIcare([R]1) (solifenacin succinate) Tablets, 5 mg and 10 mg, in the [...]

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results